Bhogireddy N, Veeramachaneni GK, Ambatipudi NVK, Mathi P, Ippaguntla J, Ganta UR, Adusumalli SG, Bokka VR. Inferences from the ADMET analysis of predicted inhibitors to Follicle Stimulating Hormone in the context of infertility.
Bioinformation 2013;
9:788-91. [PMID:
24023422 PMCID:
PMC3766312 DOI:
10.6026/97320630009788]
[Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2013] [Revised: 08/21/2013] [Accepted: 08/22/2013] [Indexed: 01/01/2023] Open
Abstract
Follicle stimulating hormone (FSH) is a glycoprotein secreted by gonadotrophs of the anterior pituitary gland that regulates
reproduction in mammals. FSH targets its receptor (FSHR) expressed only on grannulosa cells and induce the maturation of
ovarian follicles in females. The levels of both FSH and FSHR rise until the middle of estrus cycle and then falls on level at the time
of ovulation. It is associated with stimulated sertoli cell proliferation in testes and supports spermatogenesis in males. The
interaction between the polypeptide FSH hormone and its corresponding receptor is highly selective. Therefore, it is of interest to
inhibit FSH in the context of infertility. The structure of FSH (PDB ID: 1XWD) is screened using molecular docking techniques
against the ZINC database (a database of 2.7 million compounds) with reference to known standard compounds. This exercise
identifies compounds with better binding and ADMET (Absorption, Digestion, Metabolism, Excretion and Toxicity) properties
compared to known standard compounds. These observations find application for the consideration of such compounds for further
validation towards inhibiting the FSH.
Collapse